Friday, September 30, 2016 3:34:13 PM
Addiction:
Why The War on Drugs Is a Huge Failure:
Medical experts call for global drug decriminalisation:
http://www.theguardian.com/society/2016/mar/24/medical-experts-call-for-global-drug-decriminalisation
I believe overall, that based on this information the modern countries will eventually adopt the views above. I believe that illicit drugs will eventually be incorporated into society and the consolidarity of constant war and criminalization on illicit drugs will cease and be replaced by consolation, nonprofit organization support and community support by those addicted to prescription medication and illegal drugs.
Such a spectrum of care has already been developing and ELTP's choice of using Naltrexone in their anti-abuse medication was and is a wise choice.
What is the BioCorRx Recovery Program? | BioCorRx | Naltrexone Implant:
I view anti-abuse drugs at the fore-front that will be provided in hospitals, adult care homes and clinics as a way to discourage abuse in a none-invasive / none-forceful way.
In short, I see companies such as this riding on this new wave of perspective / knowledge.
Please note the comments above are my own thoughts and not based on actual financial numbers of ELTP or data in general on the sector itself. This is my own perspective on where society is going on how it will view medication and illicit drug use.
"The whole of science is nothing more than a refinement of everyday thinking." -Albert Einstein
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM